Thursday, November 09, 2017 8:50:41 AM
IDRA - 1.77 Pre-market now at 1.83/1.85
Idera Pharmaceuticals Presents Positive Translational and Clinical Data Update from Ongoing IMO-2125 Development Program at the 2017 Society for Immunotherapy of Cancer Annual Meeting (SITC)
Idera Pharmaceuticals Price Target Announced at $4.00/Share by H.C. Wainwright
Idera Pharmaceuticals Presents Positive Translational and Clinical Data Update from Ongoing IMO-2125 Development Program at the 2017 Society for Immunotherapy of Cancer Annual Meeting (SITC)
Idera Pharmaceuticals Price Target Announced at $4.00/Share by H.C. Wainwright
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
